Get the Stockscreener App
0.5062
3.62%
-0.0128
Sensei Biotherapeutics Inc stock is traded at $0.5062, with a volume of 79,776.
It is down -3.62% in the last 24 hours and up +0.02% over the past month.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.
See More
Previous Close:
$0.519
Open:
$0.5084
24h Volume:
79,776
Relative Volume:
0.28
Market Cap:
$12.52M
Revenue:
-
Net Income/Loss:
$-34.10M
P/E Ratio:
-0.342
EPS:
-1.48
Net Cash Flow:
$-32.20M
1W Performance:
-15.22%
1M Performance:
+0.02%
6M Performance:
-72.06%
1Y Performance:
-27.51%
1-Day Range:
$0.4865
$0.5099
1-Week Range:
$0.465
$0.59
52-Week Range:
$0.384
$1.94
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Name
Sensei Biotherapeutics Inc
Sector
Industry
Phone
(240) 243-8000
Address
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-21 | Downgrade | Berenberg | Buy → Hold |
| Jun-29-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Mar-01-21 | Initiated | Berenberg | Buy |
| Mar-01-21 | Initiated | Citigroup | Buy |
| Mar-01-21 | Initiated | Oppenheimer | Outperform |
| Mar-01-21 | Initiated | Piper Sandler | Overweight |
View All
Sensei Biotherapeutics Inc Stock (SNSE) Latest News
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences - GlobeNewswire
3 US Penny Stocks To Monitor In October 2024 - Yahoo Finance Australia
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.01% - MSN
Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price Up 6% - Defense World
Sensata Technologies Holding plc (NYSE:ST) Stock Holdings Trimmed by Mutual of America Capital Management LLC - Defense World
SeQuent Scientific hits 52-week high, surges nearly 9% in 20 minutes - Business Upturn
SENS Stock on the Rise: A Promising Investment - The InvestChronicle
Oman India Investment Fund sells shares worth Rs 75 cr in Senco Gold - The Economic Times
Latest News | Oman India Investment Fund Sells Shares Worth Rs 75 Cr in Senco Gold - LatestLY
Sensiva Health names Ben Williamson as Chief Executive Officer - WV News
Recent Insider Activity Could Benefit Sensata Technologies Holding Plc (ST) - Knox Daily
Is Seelos Therapeutics Inc (SEEL) worth investing in despite its undervalued state? - US Post News
Federated Hermes Inc. Increases Holdings in Sensata Technologies Holding plc (NYSE:ST) - Defense World
46,650 Shares in Sensata Technologies Holding plc (NYSE:ST) Purchased by Schwerin Boyle Capital Management Inc. - Defense World
Trend Tracker for (ST) - Stock Traders Daily
Benjamin Edwards Inc. Buys 169 Shares of Standex International Co. (NYSE:SXI) - Defense World
Sensei Biotherapeutics names new financial chief - Investing.com India
Senseonics (NYSE:SENS) Now Covered by Analysts at StockNews.com - Defense World
Sensei Biotherapeutics Appoints New Financial Chief - TipRanks
Are Smart Investors Making the Right Decision? Sensata Technologies Holding Plc (ST) - SETE News
Moors & Cabot Inc. Acquires 8,900 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Sensei Biotherapeutics names new financial chief By Investing.com - Investing.com South Africa
Sensata Technologies (NYSE:ST) Releases Q3 2024 Earnings Guidance - Defense World
Multibagger Alert: Senco Gold Stock Soars 300% Since IPO – Is More Growth on the Horizon? Analysts Weigh In! - Share Price India News
SYSTM Wealth Solutions LLC Lowers Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
Closing Bell Recap: Seelos Therapeutics Inc (SEEL) Ends at 0.20, Reflecting a -11.51 Downturn - The Dwinnex
Sensei Biotherapeutics’ SNS-103 shows pH-dependent antitumor efficacy - BioWorld Online
Massachusetts Financial Services Co. MA Sells 444,049 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
There is no doubt that Seelos Therapeutics Inc (SEEL) ticks all the boxes. - SETE News
Ratios Reveal: Breaking Down SenesTech Inc (SNES)’s Financial Health - The Dwinnex
Multibagger Stock: Senco Gold share price jumps over 300% from its IPO price in over 14 months. More steam left? - MSN
ST Stock Sees Surge of Approximately 2.46% in Last Five Days - Knox Daily
Multibagger Stock: Senco Gold share price jumps over 300% from its IPO price in over 14 months. More steam left? | Stock Market News - Mint
Seneca Foods stock soars to 52-week high, hits $64 mark - Investing.com
Investing in Senseonics Holdings Inc (SENS): What You Must Know - Knox Daily
Seelos Therapeutics Inc (SEEL) Stock: A Comprehensive 52-Week Review - The InvestChronicle
American Century Companies Inc. Cuts Stock Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
Seneca Foods (NASDAQ:SENEA) Share Price Crosses Above 200-Day Moving Average of $58.33 - MarketBeat
Texas Permanent School Fund Corp Has $1.97 Million Holdings in StoneX Group Inc. (NASDAQ:SNEX) - Defense World
StoneX Group (NASDAQ:SNEX) Hits New 12-Month High at $84.40 - MarketBeat
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
Headlands Technologies LLC Sells 3,234 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Perhaps timely catching Senseonics Holdings Inc (SENS) would be a good idea - SETE News
Daiwa Securities Group Inc. Has $786,000 Stock Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
Texas Permanent School Fund Corp Sells 19,179 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
SNS-201, a CD28xVISTA bispecific antibody with promising efficacy and safety profile - BioWorld Online
There is no way Sensata Technologies Holding Plc (ST) can keep these numbers up - SETE News
Sensata Technologies Holding plc (NYSE:ST) Shares Sold by Savant Capital LLC - Defense World
Sensei Biotherapeutics stock hits 52-week low at $0.51 - Investing.com
Sensei Biotherapeutics to Present Preclinical Data on - GlobeNewswire
Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference - StockTitan
Sensei Biotherapeutics Inc Stock (SNSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):